Prediction of Duration of Mechanical Ventilation in Acute Hypoxemic Respiratoty Failure
PREMIER
1 other identifier
observational
1,241
1 country
2
Brief Summary
Acute hypoxemic respiratory failure (AHRF) is a common cause of admission in intensive care units (ICUs) worldwide. We will assess machine learning (ML) techniques for prediction of prolonged duration (\> or = to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. The study was registered with ClinalTrials.gov (NCT03145974). Our aim is to identify a model with the minimum number of variables that predict duration of prolonged ventilation in AHRF patients using data as early as from the first 48 hours with machine learning algorithms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2025
CompletedFirst Submitted
Initial submission to the registry
February 3, 2025
CompletedFirst Posted
Study publicly available on registry
February 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedMarch 11, 2025
March 1, 2025
1.2 years
February 3, 2025
March 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MV duration
duration of mechanical ventilation
up to 100 weeks
Study Arms (2)
Derivation/testing cohort
The investigators will use a chort of 75% of patients, randomly selected, with data at T0, T24 and T48 after diagnosis of acute hypoxemic respiratory failure (AHRF). We will apply machine learning approaches.
Validation hohort
we will use 25% of unseen patients, randomly selected, with data at T0, T24 and T48 after diagnosis of AHRF.
Interventions
Machine learning and logistic regression for the validation cohort
Eligibility Criteria
De-identified dataset inclusing 1241 ventilated patients with AHRF admitted in a network of Spainisg ICUs.
You may qualify if:
- enotracheal intubation puls mechanical ventilation
- PaO2/FiO2 ratio \<or = 300 mmHg under MV with PEEP \>or =5 and FiO2 \>or = 0.3
You may not qualify if:
- Brain death patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jesus Villarlead
- Hospital Universitario Dr. Negrín (Las Palmas de Gran Canaria)collaborator
- Iinstituto de Salud Carlos IIIcollaborator
Study Sites (2)
Hospital Dr. Negrin
Las Palmas de Gran Canaria, Las Palmas, 35019, Spain
Hospital Universitario La Paz
Madrid, Spain
Related Publications (1)
Villar J, Gonzalez-Martin JM, Fernandez C, Soler JA, Rey-Abalo M, Mora-Ordonez JM, Ortiz-Diaz-Miguel R, Fernandez L, Murcia I, Robaglia D, Anon JM, Ferrando C, Parrilla D, Dominguez-Berrot AM, Cobeta P, Martinez D, Amaro-Harpigny A, Andaluz-Ojeda D, Fernandez MM, Gomez-Bentolila E, Steyerberg EW, Camporota L, Szakmany T. Predicting Outcome and Duration of Mechanical Ventilation in Acute Hypoxemic Respiratory Failure: The PREMIER Study. J Clin Med. 2025 Nov 7;14(22):7903. doi: 10.3390/jcm14227903.
PMID: 41302939DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jesus Villar
Fundacion Canaria Instituto de Investigación Sanitaria de Canarias
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Scientific Advisor
Study Record Dates
First Submitted
February 3, 2025
First Posted
February 7, 2025
Study Start
February 2, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 11, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
Ethical reasons